RxDoctor Payments Data

Quinn Dunlap, MD

Otolaryngology · Lexington, KYNPI 1528454881

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Intuitive Surgical at 48.1% of the total. Reporting peaked in 2024 at $3,065 and has fallen 72.3% since, to $848 in 2025.

$5,870in general payments, 2019–2025

Across 58 payments — averaging $101.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Inspire Medical Systems, Inc.$743
  • Medical Device Business Services, Inc.$701
  • Stryker$422
  • Baxter Healthcare$271
  • Smith+Nephew$209
  • plus $697 from 13 others
$1,250in research payments, 2019–2025

Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Techmah CMF, LLC$1K

What the payments were for

  • Travel & lodging$72912%
  • Food & beverage$2,43141%
  • Education$2,70946%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,870 in reported general payments places this provider in the 85th percentile of 137 otolaryngology providers in Kentucky.

See all otolaryngology providers in Kentucky

Medicare billing

Part B allowed, 2024
$141,839
Medicare patients
130
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine14$528
Fluticasone Propionate14$97
Cephalexin12$84
Oxycodone Hcl16$78
Levothyroxine Sodium13$73
Ibuprofen13$73

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →